TELA Bio (TELA) Capital Expenditures (2018 - 2026)

TELA Bio has reported Capital Expenditures for 9 years, with the latest figure at $59000.0 in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 48.25% year-over-year to $59000.0 in Q2 2026; TTM through Jun 2026 was $480000.0, a 9.77% decrease from a year earlier, with the FY2025 full-year figure at $448000.0, down 54.7% from the prior year.
• Capital Expenditures was $59000.0 for Q2 2026 at TELA Bio, down from $119000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $336000.0 in Q1 2022, with the low at $32000.0 in Q1 2025.
• Average Capital Expenditures over 5 years is $172111.1, with a median of $145500.0 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 1427.27% in 2022, then sank 89.47% in 2025.
• Over 5 years, Capital Expenditures stood at $46000.0 in 2022, then soared by 345.65% to $205000.0 in 2023, then climbed by 28.78% to $264000.0 in 2024, then sank by 65.53% to $91000.0 in 2025, then tumbled by 35.16% to $59000.0 in 2026.
• The last three Capital Expenditures figures came in at $59000.0 (Q2 2026), $119000.0 (Q1 2026), and $91000.0 (Q4 2025), per Business Quant data.